What's Happening?
The biopharmaceutical industry is facing challenges in digital transformation, with less than 30% of initiatives succeeding. A significant barrier is the lack of effective change management skills among Centre of Excellence (CoE) professionals. Research
by The Stem highlights that while technical implementation is straightforward, changing human behavior and organizational processes is difficult. CoE leaders report insufficient training in change management, leading to failed initiatives. Agile learning approaches are proposed as a solution, integrating skill development into daily workflows. This method emphasizes flexibility and continuous improvement, allowing CoE teams to adapt quickly and effectively.
Why It's Important?
The success of digital transformation in the biopharma sector is crucial for maintaining competitive advantage and improving patient outcomes. By adopting agile learning strategies, CoEs can enhance their ability to implement changes effectively, leading to better adoption of new capabilities. This approach not only benefits the organizations by reducing costs and improving efficiency but also enhances the value delivered to patients and healthcare providers. As CoEs become more adept at managing change, they can drive more significant business impact and foster innovation within the industry.
What's Next?
As more CoE leaders implement agile learning methods, the biopharma industry is expected to see increased success in digital transformation efforts. This shift will likely lead to a more proactive approach to strategic value creation, with CoEs playing a central role in driving innovation. Organizations may also see improved collaboration with external stakeholders, enhancing the overall healthcare ecosystem. Continuous upskilling of CoE professionals will be essential to sustain these improvements and ensure future readiness.
